XML 79 R34.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Shareholders' Equity (Tables)
12 Months Ended
Dec. 31, 2019
Equity [Abstract]  
Schedule of Assumptions Used in the Weighted Average Fair Value of the Stock Options Granted
The weighted average fair value of the Company’s stock options granted during 2019, 2018 and 2017 were $13.94, $13.04 and $16.78, respectively, using the following assumptions:
 
 
2019
 
2018
 
2017
Expected term (in years)
 
5.53

 
6.34

 
6.00

Expected volatility
 
23.36
%
 
25.27
%
 
22.58
%
Expected dividend yield
 
1.10
%
 
1.35
%
 
0.82
%
Risk-free interest rate
 
1.80
%
 
2.75
%
 
2.29
%

Schedule of Stock-based Compensation Expense
The Company recognized stock-based compensation expense in its Consolidated Financial Statements in 2019, 2018 and 2017 as follows:
 
 
2019
 
2018
 
2017
Stock-based compensation expense
 
$
24,582

 
$
23,805

 
$
36,366

Less: Deferred tax benefit
 
(4,814
)
 
(5,078
)
 
(7,891
)
Stock-based compensation expense, net of tax
 
$
19,768

 
$
18,727

 
$
28,475


Schedule of Stock Option Plans
This table presents certain information relating to the Company’s stock option plans for 2019, 2018 and 2017:
 
 
Number of
Shares
 
Weighted
Average Price
Balance as of December 31, 2016
 
18,069,000

 
$
31.57

Granted
 
2,057,000

 
69.87

Exercised
 
(2,370,000
)
 
21.22

Expired or canceled
 
(1,044,000
)
 
33.42

Balance as of December 31, 2017
 
16,712,000

 
$
37.63

Granted
 
2,468,000

 
49.94

Exercised
 
(3,232,000
)
 
25.93

Expired or canceled
 
(135,000
)
 
49.58

Balance as of December 31, 2018
 
15,813,000

 
$
41.84

Granted
 
2,480,000

 
64.04

Exercised
 
(2,243,000
)
 
25.27

Expired or canceled
 
(344,000
)
 
55.07

Balance as of December 31, 2019
 
15,706,000

 
$
47.43

 
 
 
 
 
Exercisable as of December 31, 2019
 
8,214,000

 
$
37.34

Available for future grant as of December 31, 2019
 
19,639,000

 
 

Schedule of Stock Options Outstanding and Exercisable
This table summarizes information relating to all options outstanding and exercisable at December 31, 2019:
 
 
 
Options Outstanding at December 31, 2019
 
Options Exercisable at December 31, 2019
Range of Exercise Prices (Per Share)
Number of Shares
 
Weighted Average
Exercise Price
(Per Share)
 
Weighted Average
Remaining
Contractual
Life (Years)
 
Number of Shares
 
Weighted Average
Exercise Price
(Per Share)
 
Weighted Average
Remaining
Contractual
Life (Years)
$
14.62

-
$
21.05

843,000

 
$
15.79

 
2.00
 
843,000

 
$
15.79

 
2.00
22.45

-
23.86

1,869,000

 
23.04

 
2.16
 
1,869,000

 
23.04

 
2.16
27.03

-
40.64

2,945,000

 
37.24

 
4.57
 
2,072,000

 
35.81

 
4.39
45.99

-
53.16

4,062,000

 
49.01

 
8.09
 
1,855,000

 
49.62

 
7.00
53.34

-
71.12

5,987,000

 
63.43

 
8.36
 
1,575,000

 
53.40

 
6.07
 
 
 
15,706,000

 
 
 
 
 
8,214,000

 
 
 
 

Schedule of Common Stock Buyback The following table provides the total number of shares repurchased and the related total costs in 2019, 2018 and 2017:
Year
 
Total Number of
Shares Repurchased
 
Total Cost
2019
 
6,225,000

 
$
348,348

2018
 
6,744,000

 
404,759

2017
 
4,403,000

 
248,114